| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 10/10/2007 | EP1842846A1 Phenylpiperidine derivatives as melanocortin-4 receptor modulators |
| 10/10/2007 | EP1842845A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss |
| 10/10/2007 | EP1841756A1 3-heterocyclyl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity |
| 10/10/2007 | EP1841741A1 Piperidine derivatives as prodrugs of potassium channel inhibitors |
| 10/10/2007 | EP1841740A1 3,4,(5)-substituted tetrahvdropyridines |
| 10/10/2007 | EP1841739A1 Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon2-yl)methyl] piperidine or its salt thereof via novel intermediate |
| 10/10/2007 | EP1841731A1 Substituted aminomethylene sulphonamides, production and use thereof as medicaments |
| 10/10/2007 | EP1841730A1 Cathepsin k inhibitors and atherosclerosis |
| 10/10/2007 | EP1841533A2 Base stable ionic liquids |
| 10/10/2007 | EP1610792B1 Calcium channel blockers comprising two benzhydril moieties |
| 10/10/2007 | EP1232150B1 Urea derivatives as anti-inflammatory agents |
| 10/10/2007 | CN101052618A 2-aminopyridine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease |
| 10/10/2007 | CN101050200A 1 ¿C olefin substitutional N (2,6 dimethyl phenyl) - 2 ¿C piperidine formamide derivative |
| 10/10/2007 | CN100341870C Glycosidase inhibitors and preparation thereof |
| 10/09/2007 | US7279601 Optically active α-aminooxyketone derivatives and process for production thereof |
| 10/09/2007 | US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy |
| 10/09/2007 | US7279574 Heat conductivity, it is also useful as an insulating material requiring high heat releasability such as a printed circuit substrate |
| 10/09/2007 | US7279492 Photostability; enhanced pharmacological activity |
| 10/09/2007 | US7279491 Phenylpiperidines and phenylpyrrolidines |
| 10/09/2007 | US7279478 Cathepsin cysteine protease inhibitors |
| 10/09/2007 | US7279477 Cardiovascular disease, diabetes, acidosis, cancer, obesity; such as 1-butyl-3,3-dimethyl-1-(4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl -ethyl)-phenyl)-thiourea |
| 10/09/2007 | US7279472 cathepsins inhibitors such as N-(4-Cyano-methyl-piperidin-4-yl)-3-cyclohexyl-2-(3-oxo-3H-isoindol-1-ylamino)-propionamide, used for treating autoimmune diseases such as arthritis, multiple sclerosis, asthma and osteoporosis |
| 10/09/2007 | US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 10/09/2007 | US7279314 Chemical substance having morphogenetic and growth-accelerating activities |
| 10/04/2007 | WO2007112368A1 Preparation of (r)-3-aminopiperidine dihydrochloride |
| 10/04/2007 | WO2007111706A2 Organic compounds |
| 10/04/2007 | WO2007111027A1 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent |
| 10/04/2007 | WO2007110884A2 A process for the preparation of highly pure anhydrous fexofenadine hydrochloride |
| 10/04/2007 | WO2007110667A1 Piperidines and related compounds for the treatment of dementia |
| 10/04/2007 | WO2007110449A1 Benzenesulfonamide compounds and their use |
| 10/04/2007 | WO2006131836A3 Compounds and compositions for use in the prevention and treatment of obesity and related syndromes |
| 10/04/2007 | WO2006074270A3 Synthesis of ccr5 receptor antagonists |
| 10/04/2007 | US20070232807 catalytic carboxylation of 3-methylpyridine to form nicotinic acid in presence of manganese bromide and in an aqueous solvent under supercritical conditions |
| 10/04/2007 | US20070232768 Alkoxyamines Containing a Radically Polymerizable Group |
| 10/04/2007 | US20070232661 Hedgehog Pathway Antagonists |
| 10/04/2007 | US20070232653 Process for the preparation of enantiomerically enriched cyclic beta-aryl or heteroaryl carbocyclic acids |
| 10/04/2007 | US20070232652 Serotonin transporter (sert) inhibitors for the treatment of depression and anxiety |
| 10/04/2007 | US20070232635 Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonists |
| 10/04/2007 | US20070232634 Tetrahydropyridines with central nervous system activity |
| 10/04/2007 | US20070232606 Compounds and Compositions as Cathepsin S Inhibitors |
| 10/04/2007 | US20070232581 Alzheimer's disease; compounds inhibit the production of A beta -peptide; improved pharmacokinetics; N-((4-amino-3,5-dichlorobenzylamino)(amino)methylene)-3-(isobutoxyimino)-3-(4-methoxyphenyl)propanamide |
| 10/04/2007 | CA2647290A1 Piperidines and related compounds for the treatment of dementia |
| 10/04/2007 | CA2645281A1 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent |
| 10/04/2007 | CA2629836A1 Benzeneszkfibate salts and their use as intermediates for the synthesis of 2-[2-(1-alkyl-2-piperidyl)ethyl] cinnamanilides |
| 10/04/2007 | CA2629351A1 Organic compounds |
| 10/03/2007 | EP1838673A1 Process for making substituted piperidines |
| 10/03/2007 | EP1838672A1 4-piperidinol tertiary amines as histamine 3 receptor inhibitors for the treatment of obesity and other cns disorders |
| 10/03/2007 | EP1663232B1 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 10/03/2007 | EP1304324B1 Serotonin reuptake inhibitors |
| 10/03/2007 | CN101048405A Aryl-substituted piperazine derivatives |
| 10/03/2007 | CN101048379A Lercanidipine salts |
| 10/03/2007 | CN101048378A Process for the synthesis of n-alkoxyamines |
| 10/03/2007 | CN101048375A Amino, amino acid or peptide conjugates of retinoic acid |
| 10/03/2007 | CN101048369A Biphenyloxyacetic acid derivatives for the treatment of respiratory disease |
| 10/03/2007 | CN101048161A Arylthiobenzylpiperidine derivates |
| 10/03/2007 | CN101045731A S-type clopidogrel and preparation method of its salt |
| 10/03/2007 | CN100340293C Hair growth stimulants, percutaneous preparations and method of stimulating hair growth |
| 10/02/2007 | US7276612 For hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides |
| 10/02/2007 | US7276610 Aryl piperidine amides |
| 10/02/2007 | US7276609 Process for preparing 4-(hydroxy)-[1,4′]bipiperidinyl-l'carboxylic acid tert-butyl ester |
| 10/02/2007 | US7276607 5-HT7 receptor antagonists |
| 10/02/2007 | US7276511 E.g., N-{2-(3,4-dichlorophenyl)-2-[(3,3-diphenylpropionyl)-methylamino]-4-{spiro[benzo(c)thiophene-1(3H),4'-piperidine]-(2S)-oxide}-1'-yl-butyl}-3,3,3-trifluoro-N-methyl-propionamide hydrochloride, NK-1 or NK-2 receptor antagonists; used to treat irritable bowel syndrome, pain, anxiety and vomiting |
| 10/02/2007 | US7276509 Substance P; 2-(phenyl)-4-(3-oxo-piperazin-1-yl-)-piperidine-1-carboxylic acid; benzyl-methylamide; antagonists of the NK1 receptor; antidepressant, antiolytic; antiemetic |
| 10/02/2007 | CA2349013C Intermediate for the synthesis of amlodipine, a process for the preparation thereof and corresponding use |
| 09/27/2007 | WO2007108210A1 Hair dying composition |
| 09/27/2007 | WO2007108209A1 Hair dying composition |
| 09/27/2007 | WO2007108011A2 Process for the preparation of highly pure donepezil |
| 09/27/2007 | WO2007107550A1 Adamantane derivatives for the treatment of the metabolic syndrome |
| 09/27/2007 | WO2007107352A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions |
| 09/27/2007 | WO2007107311A2 Organic sulphinic acid derivatives |
| 09/27/2007 | WO2007107008A1 Compounds and compositions for use in the prevention and treatment of disorders of fat metabolism and obesity |
| 09/27/2007 | WO2007079929A3 Substituted tricyclic piperidone derivatives |
| 09/27/2007 | US20070225499 Process for the Preparation of 2,2-Disubstituted Pyrroles |
| 09/27/2007 | US20070225377 Bridged Ring Structures as Pharmaceutical Agents |
| 09/27/2007 | US20070225372 Amides as Bace Inhibitors |
| 09/27/2007 | US20070225331 4,4-Disubstituted piperidines, and methods of use thereof |
| 09/27/2007 | US20070225296 Arylalkylamine Compound and Process for Preparing the Same |
| 09/27/2007 | US20070225288 Indene Derivatives and Process for the Preparation Thereof |
| 09/27/2007 | US20070225229 N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators |
| 09/27/2007 | CA2646588A1 Adamantane derivatives for the treatment of the metabolic syndrome |
| 09/27/2007 | CA2646541A1 Agents that disrupt cellular replication and their use in inhibiting pathological conditions |
| 09/26/2007 | EP1836168A1 Benzoyl-tetrahydropyridine as glyt-1 inhibitors |
| 09/26/2007 | EP1836161A2 Methods and compositions for treating amyloid-related diseases |
| 09/26/2007 | EP1451153B1 Nk1 antagonists |
| 09/26/2007 | EP1228367B1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof |
| 09/26/2007 | CN101044116A 4-phenylsulfonamidopiperidines as calcium channel blockers |
| 09/26/2007 | CN101044115A Piperidines and related compounds for treatment of alzheimer's disease |
| 09/26/2007 | CN101044112A O-aminophenol derivatives and colorants containing these compounds |
| 09/26/2007 | CN101041660A 1,2-dihydrogen pyridine derivative, carbon glycosides intermediate and preparation method and application thereof |
| 09/26/2007 | CN100339371C Novel aryloxy-alkyl-dialkylamines compound |
| 09/25/2007 | US7273946 Nitroxy derivatives, e.g., 4-(nitrooxy)butyl [1R-[1 alpha (Z),2 alpha (R*),3 alpha ,5 alpha ]]-7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-5-heptenoate; used for the treatment of glaucoma and ocular hypertension |
| 09/25/2007 | US7273878 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 09/25/2007 | US7273867 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents |
| 09/25/2007 | US7273863 Benzophenones as inhibitors of reverse transcriptase |
| 09/25/2007 | US7273856 Antagonist of tachykinins like neurokinins and drugs |
| 09/25/2007 | CA2415551C Aniline derivatives |
| 09/25/2007 | CA2370834C Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders |
| 09/20/2007 | WO2007106705A1 Soluble epoxide hydrolase inhibitors and methods of using same |
| 09/20/2007 | WO2007106525A1 Piperidinyl, indolyl, pirinidyl, morpholinyl and benzimidazolyl urea derivatives as inhibitors of soluble epoxide hydrolase for the treatment of hypertension, inflammations and other diseases |
| 09/20/2007 | WO2007104652A2 Non-peptidic renin inhibitors nitroderivatives |